Table 1.
Targeted gene | Increase in mutation frequency † | Cancer susceptibility | Sites of cancer | Reference no. |
---|---|---|---|---|
Msh2 | 7–160 | Cancer prone | lymphoma | ( 14, 15, 16 ) |
GI tract | ||||
Skin | ||||
Msh3 | 2 | Low ‡ | GI tract | ( 21 ) |
Msh6 | 2–13 | Cancer prone | Lymphoma | ( 19 ) |
GI tract | ||||
Mlh1 | 7–100 | Cancer prone | GI tract | ( 20, 22 ) |
Lymphoma | ||||
Mlh3 | – | Cancer prone | GI tract | ( 17 ) |
Lymphoma | ||||
Pms1 | – | No | ( 20 ) | |
Pms2 | 5–100 | Cancer prone | Lymphoma | ( 20 ) |
Sarcoma |